Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Ovarian Neoplasms

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 41 articles: HTML format Text format

Single Articles

January 2012
1. HARTGE P , Speyer JL
   Finding Ovarian Cancer.
   J Natl Cancer Inst. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. LIM AW , Mesher D, Gentry-Maharaj A, Balogun N, et al
   Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes.
   J Natl Cancer Inst. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. ANDRIOLE GL , Crawford ED, Grubb RL 3rd, Buys SS, et al
   Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up.
   J Natl Cancer Inst. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
4. NICK AM , Stone RL, Armaiz-Pena G, Ozpolat B, et al
   Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.
   J Natl Cancer Inst. 2011;103:1596-612.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. URBAN N , Thorpe JD, Bergan LA, Forrest RM, et al
   Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer.
   J Natl Cancer Inst. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. SCHMIDT C
   CA-125: a biomarker put to the test.
   J Natl Cancer Inst. 2011;103:1290-1.
   PubMed     Text format     Related articles   
   
   
   
   August 2011
7. BROWER V
   Ovarian Cancer Genome Sequencing Unveils Findings.
   J Natl Cancer Inst. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
8. SCHMIDT C
   Ovarian Cancer Treatments on the Horizon.
   J Natl Cancer Inst. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. 
   StatBite Ovarian Cancer, Five-Year Stage-Specific Relative Survival Rates (2004-2008).
   J Natl Cancer Inst. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
10. CRANE K
    Oral Contraceptives as Ovarian Cancer Prevention.
    J Natl Cancer Inst. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. LEE CK , Friedlander M, Brown C, Gebski VJ, et al
    Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.
    J Natl Cancer Inst. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. LE XF , Mao W, He G, Claret FX, et al
    The Role of p27Kip1 in Dasatinib-Enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells.
    J Natl Cancer Inst. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
13. TAMMEMAGI CM , Pinsky PF, Caporaso NE, Kvale PA, et al
    Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation.
    J Natl Cancer Inst. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
14. DREW Y , Mulligan EA, Vong WT, Thomas HD, et al
    Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.
    J Natl Cancer Inst. 2011;103:334-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. MARTIN M
    Materials scientists join oncologists to explore nano- and microtherapeutics.
    J Natl Cancer Inst. 2011;103:172-3.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
16. FRUSCIO R , Garbi A, Parma G, Lissoni AA, et al
    Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer.
    J Natl Cancer Inst. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
17. WACHOLDER S , Han SS, Weinberg CR
    Inference From a Multiplicative Model of Joint Genetic Effects or Ovarian Cancer Risk.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
18. RAMUS SJ , Kartsonaki C, Gayther SA, Pharoah PD, et al
    Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. TUMA RS
    Targeted epigenetic therapies: the next frontier?
    J Natl Cancer Inst. 2010;102:1824-5.
    PubMed     Text format     Related articles   
    
    
    
    
20. METCALFE K , Lubinski J, Lynch HT, Ghadirian P, et al
    Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
    J Natl Cancer Inst. 2010;102:1874-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
21. MUGGIA F , Cannon T, Safra T, Curtin J, et al
    Delayed Neoplastic and Renal Complications in Women Receiving Long-term Chemotherapy for Recurrent Ovarian Cancer.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
22. ORTOLAN E , Ferrero E, Funaro A
    Re: CD157 in ovarian carcinoma: How does it help us?
    J Natl Cancer Inst. 2010;102:1741.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
23. HOSKINS P , Vergote I, Cervantes A, Tu D, et al
    Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin-Topotecan and Carboplatin-Paclitaxel vs Carboplatin-Paclitaxel.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MCGUIRE WP
    Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
25. 
    StatBite BRCA Mutations in Breast Cancer Patients Under Age 50 Tested for Mutations.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
26. CALCAGNO AM , Salcido CD, Gillet JP, Wu CP, et al
    Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. DIAMANDIS EP
    Cancer biomarkers: can we turn recent failures into success?
    J Natl Cancer Inst. 2010;102:1462-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
28. 
    StatBite: Lynch syndrome increases the risk of various cancers.
    J Natl Cancer Inst. 2010;102:1383.
    PubMed     Text format     Related articles   
    
    
    
    
29. VALDES R , Del Priore G
    Re: Predictive Value of Symptoms for Early Detection of Ovarian Cancer.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
30. JORDAN SJ , Coory MD, Webb PM
    Re: Predictive Value of Symptoms for Early Detection of Ovarian Cancer.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
31. ANNUNZIATA CM , Birrer MJ
    CD157 in ovarian carcinoma: how does it help us?
    J Natl Cancer Inst. 2010;102:1104-5.
    PubMed     Text format     Related articles   
    
    
    
    
32. ORTOLAN E , Arisio R, Morone S, Bovino P, et al
    Functional role and prognostic significance of CD157 in ovarian carcinoma.
    J Natl Cancer Inst. 2010;102:1160-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
33. GOOZNER M
    Personalizing Ovarian Cancer Screening.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
34. LIU G , Yang G, Chang B, Mercado-Uribe I, et al
    Stanniocalcin 1 and ovarian tumorigenesis.
    J Natl Cancer Inst. 2010;102:812-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
35. 
    StatBite BRCA Mutations Increase Risk of Breast/Ovarian Cancer.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
36. TRIMBOS B , Timmers P, Pecorelli S, Coens C, et al
    Surgical Staging and Treatment of Early Ovarian Cancer: Long-term Analysis From a Randomized Trial.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. HOCKING WG , Hu P, Oken MM, Winslow SD, et al
    Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
38. AYANIAN JZ
    Racial Disparities in Outcomes of Colorectal Cancer Screening: Biology or Barriers to Optimal Care?
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
39. LAIYEMO AO , Doubeni C, Pinsky PF, Doria-Rose VP, et al
    Race and Colorectal Cancer Disparities: Health-Care Utilization vs Different Cancer Susceptibilities.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
40. ROSSING MA , Wicklund KG, Cushing-Haugen KL, Weiss NS, et al
    Predictive Value of Symptoms for Early Detection of Ovarian Cancer.
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. CASS I , Karlan BY
    Ovarian Cancer Symptoms Speak Out--But What Are They Really Saying?
    J Natl Cancer Inst. 2010.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: